In addition, KCNQ1OT1 can upregulate Ezrin, a protein differentially expressed in aggressive cancer types and associated with poor survival [49], and promote cisplatin resistance of CAL27-res and SCC9-res cells through binding with miR-211-5p (Table 1). This evidence concerns the gene KCNQ1OT1 and cancer.